Innovative financing for HIV response in sub–Saharan Africa
In 2015 around 15 million people living with HIV were receiving antiretroviral treatment (ART) in sub–Saharan Africa. Sustained provision of ART, though both prudent and necessary, creates substantial long–term fiscal obligations for countries affected by HIV/AIDS. As donor assistance for health r...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Edinburgh University Global Health Society
2016-06-01
|
Series: | Journal of Global Health |
Subjects: | |
Online Access: | http://www.jogh.org/documents/issue201601/jogh-06-010407.pdf |
id |
doaj-ec26c9d935494290aaad0f46d5a02fd5 |
---|---|
record_format |
Article |
spelling |
doaj-ec26c9d935494290aaad0f46d5a02fd52020-11-24T21:46:47ZengEdinburgh University Global Health SocietyJournal of Global Health2047-29782047-29862016-06-016110.7189/jogh.06.010407Innovative financing for HIV response in sub–Saharan Africa Rifat Atun0Sachin Silva1Mthuli Ncube2Anna Vassall3Harvard T.H. Chan School of Public Health, Harvard University, Boston, USAHealth Policy Programme, Imperial College London, London, UKBlavatnik School of Government, Oxford University, Oxford, UKLondon School of Hygiene and Tropical Medicine, London, UKIn 2015 around 15 million people living with HIV were receiving antiretroviral treatment (ART) in sub–Saharan Africa. Sustained provision of ART, though both prudent and necessary, creates substantial long–term fiscal obligations for countries affected by HIV/AIDS. As donor assistance for health remains constrained, novel financing mechanisms are needed to augment funding domestic sources. We explore how Innovative Financing has been used to co–finance domestic HIV/AIDS responses. Based on analysis of non–health sectors, we identify innovative financing instruments that could be used in the HIV response.http://www.jogh.org/documents/issue201601/jogh-06-010407.pdfHIVfinancingsub-Saharan Africa |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rifat Atun Sachin Silva Mthuli Ncube Anna Vassall |
spellingShingle |
Rifat Atun Sachin Silva Mthuli Ncube Anna Vassall Innovative financing for HIV response in sub–Saharan Africa Journal of Global Health HIV financing sub-Saharan Africa |
author_facet |
Rifat Atun Sachin Silva Mthuli Ncube Anna Vassall |
author_sort |
Rifat Atun |
title |
Innovative financing for HIV response in sub–Saharan Africa |
title_short |
Innovative financing for HIV response in sub–Saharan Africa |
title_full |
Innovative financing for HIV response in sub–Saharan Africa |
title_fullStr |
Innovative financing for HIV response in sub–Saharan Africa |
title_full_unstemmed |
Innovative financing for HIV response in sub–Saharan Africa |
title_sort |
innovative financing for hiv response in sub–saharan africa |
publisher |
Edinburgh University Global Health Society |
series |
Journal of Global Health |
issn |
2047-2978 2047-2986 |
publishDate |
2016-06-01 |
description |
In 2015 around 15 million people living with HIV were receiving antiretroviral treatment (ART) in sub–Saharan Africa. Sustained provision of ART, though both prudent and necessary, creates
substantial long–term fiscal obligations for countries affected by HIV/AIDS. As donor assistance for health remains constrained, novel financing mechanisms are needed to augment funding domestic sources. We explore how Innovative Financing has been used to co–finance domestic HIV/AIDS responses. Based on analysis of non–health sectors, we identify innovative financing instruments that could be used in the HIV response. |
topic |
HIV financing sub-Saharan Africa |
url |
http://www.jogh.org/documents/issue201601/jogh-06-010407.pdf |
work_keys_str_mv |
AT rifatatun innovativefinancingforhivresponseinsubsaharanafrica AT sachinsilva innovativefinancingforhivresponseinsubsaharanafrica AT mthulincube innovativefinancingforhivresponseinsubsaharanafrica AT annavassall innovativefinancingforhivresponseinsubsaharanafrica |
_version_ |
1725900004390862848 |